Regeneus (ASX: RGS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Regeneus Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Regeneus (ASX: RGS)
Latest News
No posts found.
RGS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Regeneus
Regeneus Ltd. is regenerative medicine company. It develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Pymble, Australia.
RGS Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 09 Apr 2024 | $0.01 | $0.00 | 0.00% | 4,275,678 | $0.01 | $0.01 | $0.01 |
| 08 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,683,175 | $0.01 | $0.01 | $0.01 |
| 05 Apr 2024 | $0.01 | $0.01 | 200.00% | 25,868,187 | $0.01 | $0.02 | $0.01 |
| 27 Mar 2024 | $0.01 | $0.00 | 0.00% | 206,029 | $0.01 | $0.01 | $0.01 |
| 22 Mar 2024 | $0.01 | $0.00 | 0.00% | 125,000 | $0.01 | $0.01 | $0.01 |
| 21 Mar 2024 | $0.01 | $0.00 | 0.00% | 70,193 | $0.01 | $0.01 | $0.01 |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Vincent Harold Pendal | Non-Executive Director | Oct 2002 |
--
|
| Mr Athanasio John Traicos | Non-Executive Director | Oct 2002 |
--
|
| Mr Timothy Maxwell Clifton | Non-Executive Director | Oct 2002 |
--
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Westpac Custodian Nominees Ltd | 8,070,253 | 12.47% |
| National Nominees Ltd | 6,885,885 | 10.64% |
| Chase Manhattan Nominees Ltd | 4,891,661 | 7.56% |
| Perpetual Trustees Nominees Ltd | 3,757,397 | 5.81% |
| Nattai Pty Ltd | 2,465,173 | 3.81% |
| Lyrebird Pty Ltd | 2,340,242 | 3.48% |
| Aurex Pty Ltd | 2,225,810 | 3.31% |
| Ucone Pty Ltd | 2,164,823 | 3.35% |
| Permanent Trustee Australia Ltd | 1,937,275 | 2.99% |
| Queensland Investment Corporation | 1,736,491 | 2.68% |
| Shar Holdings Pty Ltd | 1,633,278 | 2.43% |
| AMP Life Ltd | 1,611,391 | 2.49% |
| Yandal Investments Pty Ltd | 1,600,000 | 2.38% |
| Shar Holdings Pt Ltd | 1,583,278 | 2.45% |
| BOS Management Pty Ltd | 1,561,888 | 2.32% |
| HSBC Custody Nominees (Australia) Ltd | 1,528,264 | 2.27% |
| Gabor Holding Pty Ltd | 1,500,000 | 2.23% |
| Permanent Trustee Australia Ltd (FIR0023 A/c) | 1,440,275 | 2.14% |
| Ranger Gold Pty Ltd | 1,270,848 | 1.96% |
| Ranger Gold Pty Ltd (AC Applecross Gold Partners) | 1,270,848 | 1.89% |
| Mercantile Mutual Life Insurance Co Ltd | 1,213,184 | 1.80% |
| Merriment Nominees Pty Ltd (Eastwood Family Fund A/c) | 1,086,464 | 1.61% |
| Merriment Nominees Pty Ltd | 1,068,000 | 1.65% |
| AMP Nominees Pty Ltd | 1,031,326 | 1.59% |
| John Alexander Christie | 966,678 | 1.49% |
| Monica Theresia Dunnet | 792,857 | 1.23% |
